FI47365C - Process for the preparation of new therapeutically active indolder t. - Google Patents

Process for the preparation of new therapeutically active indolder t.

Info

Publication number
FI47365C
FI47365C FI61667A FI61667A FI47365C FI 47365 C FI47365 C FI 47365C FI 61667 A FI61667 A FI 61667A FI 61667 A FI61667 A FI 61667A FI 47365 C FI47365 C FI 47365C
Authority
FI
Finland
Prior art keywords
indolder
preparation
therapeutically active
new therapeutically
new
Prior art date
Application number
FI61667A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI47365B (en
Inventor
Troxler
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI47365B publication Critical patent/FI47365B/fi
Application granted granted Critical
Publication of FI47365C publication Critical patent/FI47365C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
FI61667A 1966-03-04 1967-03-02 Process for the preparation of new therapeutically active indolder t. FI47365C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH315466A CH472404A (en) 1966-03-04 1966-03-04 Process for the production of new indole derivatives

Publications (2)

Publication Number Publication Date
FI47365B FI47365B (en) 1973-07-31
FI47365C true FI47365C (en) 1973-11-12

Family

ID=4249777

Family Applications (1)

Application Number Title Priority Date Filing Date
FI61667A FI47365C (en) 1966-03-04 1967-03-02 Process for the preparation of new therapeutically active indolder t.

Country Status (7)

Country Link
AT (1) AT266112B (en)
CH (1) CH472404A (en)
CS (1) CS156406B2 (en)
DK (1) DK121168B (en)
ES (1) ES337457A1 (en)
FI (1) FI47365C (en)
SE (1) SE308720B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1357A1 (en) * 1979-12-07 1981-08-10 Hoffmann La Roche 2,3-INDOLEDIONE DERIVATIVES
ATE502635T1 (en) 2002-08-19 2011-04-15 Pfizer COMBINATION THERAPY AGAINST HYPERPROLIFERATIVE DISEASES
GT200600381A (en) 2005-08-25 2007-03-28 ORGANIC COMPOUNDS
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
US11248001B2 (en) 2019-01-18 2022-02-15 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
FI47365B (en) 1973-07-31
CH472404A (en) 1969-05-15
SE308720B (en) 1969-02-24
ES337457A1 (en) 1968-03-01
DK121168B (en) 1971-09-20
CS156406B2 (en) 1974-07-24
AT266112B (en) 1968-11-11

Similar Documents

Publication Publication Date Title
FI48460C (en) Process for the preparation of pharmacologically active novel amino-dihalophenylethylamines.
FI48590C (en) Process for the preparation of therapeutically useful azaspiroalkandion compounds.
FI50707C (en) Process for the preparation of new pharmacologically active hydroxycyclohexylamines.
FI52335C (en) Process for the preparation of therapeutically active ethylamine derivatives.
FI44619C (en) Process for the preparation of novel therapeutically active substituted phenylacetic acids.
FI47365C (en) Process for the preparation of new therapeutically active indolder t.
FI46251C (en) Process for the preparation of new therapeutically active phenoxypropyl lamines.
FI49512C (en) Process for the preparation of novel therapeutically active s-triazinyl-piperazine derivatives.
FI52857C (en) Process for the preparation of therapeutically active amidoximes.
FI45551C (en) Process for the preparation of therapeutically useful dehydroepiandro osterone monanthate.
FI46961C (en) Process for the preparation of therapeutically active 5-nitroimidazole bamates
FI47881C (en) Process for the preparation of therapeutically active substituted phenylacetamides
FI47189C (en) Process for the preparation of therapeutically active d-lysergic acid-N-phenylpiperazides.
FI45045C (en) Process for the preparation of novel therapeutically active 5-nitro-2-furyl-isoxazole derivatives.
FI48724C (en) Process for the preparation of N-carbamoyloxyphenyl carbamates.
FI48576C (en) Process for the preparation of therapeutically active alpha-fluoromalic acid derivatives.
FI47092C (en) Process for the preparation of therapeutically valuable mixture-substituted 1-phenoxy-3-alkylaminopropanols- (2).
FI47100C (en) Process for the preparation of therapeutically active 1-p-chlorobenzoyl-2-lower-alkyl-5-lower-alkoxy-3-indolyl-acetic acid.
FI45954C (en) Process for the preparation of therapeutically active benzenesulfonylcuramides.
FI48190C (en) Process for the preparation of therapeutically active 10alpha-methoxy-9,10-dihydroergoline derivatives
FI50879C (en) Process for the preparation of therapeutically active substituted 3-aminoacylamino-thiophenes.
FI49162C (en) Process for the preparation of therapeutically useful 3-indolyl-aliphatic acid derivatives.
FI48732C (en) Process for the preparation of pharmacologically active 3-substituted-α-mino-1,2,3,4-tetrahydrocarbazoles.
FI48081C (en) Process for the preparation of pharmacologically active 1-sulfanilyl-2-in mino-3-R-imidazolidines
FI48587C (en) Process for the preparation of novel, therapeutically active 4-amino-tetra hydroquinoline derivatives.